• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参数反应图是一种用于早期癌症治疗结果的成像生物标志物。

The parametric response map is an imaging biomarker for early cancer treatment outcome.

作者信息

Galbán Craig J, Chenevert Thomas L, Meyer Charles R, Tsien Christina, Lawrence Theodore S, Hamstra Daniel A, Junck Larry, Sundgren Pia C, Johnson Timothy D, Ross David J, Rehemtulla Alnawaz, Ross Brian D

机构信息

Departments of Radiology, University of Michigan, Center for Molecular Imaging, Ann Arbor, USA.

出版信息

Nat Med. 2009 May;15(5):572-6. doi: 10.1038/nm.1919. Epub 2009 Apr 19.

DOI:10.1038/nm.1919
PMID:19377487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3307223/
Abstract

Here we describe the parametric response map (PRM), a voxel-wise approach for image analysis and quantification of hemodynamic alterations during treatment for 44 patients with high-grade glioma. Relative cerebral blood volume (rCBV) and flow (rCBF) maps were acquired before treatment and after 1 and 3 weeks of therapy. We compared the standard approach using region-of-interest analysis for change in rCBV or rCBF to the change in perfusion parameters on the basis of PRM (PRM(rCBV) and PRM(rCBF)) for their accuracy in predicting overall survival. Neither the percentage change of rCBV or rCBF predicted survival, whereas the regional response evaluations made on the basis of PRM were highly predictive of survival. Even when accounting for baseline rCBV, which is prognostic, PRM(rCBV) proved more predictive of overall survival.

摘要

在此,我们描述了参数反应图(PRM),这是一种针对44例高级别胶质瘤患者治疗期间血流动力学改变进行图像分析和定量的体素级方法。在治疗前以及治疗1周和3周后获取相对脑血容量(rCBV)和血流(rCBF)图。我们将使用感兴趣区域分析来评估rCBV或rCBF变化的标准方法与基于PRM的灌注参数变化(PRM(rCBV)和PRM(rCBF))在预测总生存期方面的准确性进行了比较。rCBV或rCBF的百分比变化均不能预测生存期,而基于PRM进行的区域反应评估对生存期具有高度预测性。即使考虑到具有预后价值的基线rCBV,PRM(rCBV)在预测总生存期方面也更具优势。

相似文献

1
The parametric response map is an imaging biomarker for early cancer treatment outcome.参数反应图是一种用于早期癌症治疗结果的成像生物标志物。
Nat Med. 2009 May;15(5):572-6. doi: 10.1038/nm.1919. Epub 2009 Apr 19.
2
Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.参数响应图作为一种成像生物标志物,可区分高级别胶质瘤的进展与假性进展。
J Clin Oncol. 2010 May 1;28(13):2293-9. doi: 10.1200/JCO.2009.25.3971. Epub 2010 Apr 5.
3
High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.高级别和低级别胶质瘤:利用灌注磁共振成像进行鉴别
Clin Radiol. 2005 Apr;60(4):493-502. doi: 10.1016/j.crad.2004.09.009.
4
Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.前瞻性分析参数反应图衍生的 MRI 生物标志物:识别标准影像学评估无法预测的早期且独特的脑胶质瘤反应模式。
Clin Cancer Res. 2011 Jul 15;17(14):4751-60. doi: 10.1158/1078-0432.CCR-10-2098. Epub 2011 Apr 28.
5
Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.用动脉自旋标记法评估胶质肿瘤的灌注;与动态磁敏感对比法比较。
Eur J Radiol. 2014 Oct;83(10):1914-9. doi: 10.1016/j.ejrad.2014.07.002. Epub 2014 Jul 15.
6
Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.采用不同测量方法的灌注磁共振成像(动态对比增强磁共振成像)用于评估人脑胶质瘤中的血流和血容量。
Acta Radiol. 2012 Feb 1;53(1):95-101. doi: 10.1258/ar.2011.110242. Epub 2011 Nov 23.
7
Prognostic value of blood flow estimated by arterial spin labeling and dynamic susceptibility contrast-enhanced MR imaging in high-grade gliomas.动脉自旋标记和动态磁敏感对比增强磁共振成像评估的血流在高级别胶质瘤中的预后价值
J Neurooncol. 2014 Dec;120(3):557-66. doi: 10.1007/s11060-014-1586-z. Epub 2014 Aug 27.
8
Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.高级别胶质瘤的预后血管成像生物标志物:肿瘤通透性作为血容量估计的辅助手段。
Acad Radiol. 2013 Apr;20(4):478-85. doi: 10.1016/j.acra.2012.11.011.
9
Impact of perfusion map analysis on early survival prediction accuracy in glioma patients.灌注图分析对胶质瘤患者早期生存预测准确性的影响。
Transl Oncol. 2013 Dec 1;6(6):766-74. doi: 10.1593/tlo.13670.
10
Relative percentage signal intensity recovery of perfusion metrics—an efficient tool for differentiating grades of glioma.灌注指标的相对百分比信号强度恢复——一种区分胶质瘤等级的有效工具。
Br J Radiol. 2015 Aug;88(1052):20140784. doi: 10.1259/bjr.20140784. Epub 2015 May 27.

引用本文的文献

1
The use of diffusion-weighted magnetic resonance imaging and parametric response mapping for disease outcome prediction in nasopharyngeal carcinoma.利用扩散加权磁共振成像和参数反应映射预测鼻咽癌的疾病转归
BMC Med Imaging. 2025 Jul 31;25(1):308. doi: 10.1186/s12880-025-01847-2.
2
Applications of Advanced Imaging for Radiotherapy Planning and Response Assessment in the Central Nervous System.先进成像技术在中枢神经系统放射治疗计划与反应评估中的应用
Tomography. 2025 Jun 12;11(6):68. doi: 10.3390/tomography11060068.
3
Imaging-Based Molecular Characterization of Adult-Type Diffuse Glioma Using Diffusion and Perfusion MRI in Pre- and Post-Treatment Stage Considering Spatial and Temporal Heterogeneity.考虑空间和时间异质性,在治疗前和治疗后阶段使用扩散加权磁共振成像(DWI)和灌注加权磁共振成像(PWI)对成人型弥漫性胶质瘤进行基于影像的分子特征分析
J Magn Reson Imaging. 2025 Aug;62(2):468-479. doi: 10.1002/jmri.29781. Epub 2025 Apr 8.
4
Automated CT-based measurements of radial and longitudinal expansion of airways due to breathing-related lung volume change.基于计算机断层扫描(CT)的气道径向和纵向扩张的自动化测量,该扩张由与呼吸相关的肺容积变化引起。
Med Phys. 2025 Apr;52(4):2316-2329. doi: 10.1002/mp.17592. Epub 2024 Dec 20.
5
Parametric response mapping of co-registered intravoxel incoherent motion magnetic resonance imaging and positron emission tomography in locally advanced cervical cancer undergoing concurrent chemoradiation therapy.同步放化疗局部晚期宫颈癌中,联合配准的体素内不相干运动磁共振成像与正电子发射断层扫描的参数反应映射。
Phys Imaging Radiat Oncol. 2024 Aug 18;31:100630. doi: 10.1016/j.phro.2024.100630. eCollection 2024 Jul.
6
LungViT: Ensembling Cascade of Texture Sensitive Hierarchical Vision Transformers for Cross-Volume Chest CT Image-to-Image Translation.LungViT:用于跨容积胸部 CT 图像到图像翻译的纹理敏感层次视觉 Transformer 级联集成。
IEEE Trans Med Imaging. 2024 Jul;43(7):2448-2465. doi: 10.1109/TMI.2024.3367321. Epub 2024 Jul 1.
7
Implementation and evaluation of a dynamic contrast-enhanced MR perfusion protocol for glioblastoma using a 0.35 T MRI-Linac system.使用 0.35T MRI-Linac 系统对胶质母细胞瘤进行动态对比增强磁共振灌注方案的实施和评估。
Phys Med. 2024 Mar;119:103316. doi: 10.1016/j.ejmp.2024.103316. Epub 2024 Feb 9.
8
Pattern recognition of microcirculation with super-resolution ultrasound imaging provides markers for early tumor response to anti-angiogenic therapy.超分辨率超声成像的微循环模式识别可为肿瘤早期抗血管生成治疗反应提供标志物。
Theranostics. 2024 Jan 20;14(3):1312-1324. doi: 10.7150/thno.89306. eCollection 2024.
9
A Survey on Artificial Intelligence in Pulmonary Imaging.肺部影像人工智能研究综述
Wiley Interdiscip Rev Data Min Knowl Discov. 2023 Nov-Dec;13(6). doi: 10.1002/widm.1510. Epub 2023 Jul 7.
10
Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization.碘化油作为常规经动脉化疗栓塞后的成像生物标志物。
Eur Radiol. 2024 May;34(5):3284-3297. doi: 10.1007/s00330-023-10326-7. Epub 2023 Nov 6.

本文引用的文献

1
Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.胶质瘤:在动态磁敏感加权对比增强灌注磁共振成像中通过脑血容量测量预测进展时间或生存期
Radiology. 2008 May;247(2):490-8. doi: 10.1148/radiol.2472070898. Epub 2008 Mar 18.
2
A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone.一项可行性研究,评估功能扩散图谱作为检测转移性前列腺癌骨转移患者治疗反应的预测性成像生物标志物。
Neoplasia. 2007 Dec;9(12):1003-11. doi: 10.1593/neo.07954.
3
Model-based and model-free parametric analysis of breast dynamic-contrast-enhanced MRI.基于模型和无模型的乳腺动态对比增强磁共振成像参数分析
NMR Biomed. 2009 Jan;22(1):40-53. doi: 10.1002/nbm.1221.
4
Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.在脑胶质瘤患者灌注指标测定中,三种不同直方图分析方法与感兴趣区分析的比较。
J Magn Reson Imaging. 2007 Oct;26(4):1053-63. doi: 10.1002/jmri.21064.
5
An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone.已发生骨转移的前列腺癌早期治疗反应的一种影像学生物标志物。
Cancer Res. 2007 Apr 15;67(8):3524-8. doi: 10.1158/0008-5472.CAN-06-4236.
6
Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas.动态磁敏感对比灌注磁共振成像数据的直方图分析与感兴趣区分析在脑胶质瘤分级中的应用
AJNR Am J Neuroradiol. 2007 Apr;28(4):761-6.
7
Contrast agents and applications to assess tumor angiogenesis in vivo by magnetic resonance imaging.用于通过磁共振成像在体内评估肿瘤血管生成的造影剂及其应用。
Curr Med Chem. 2007;14(1):77-91. doi: 10.2174/092986707779313516.
8
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents.抗血管生成和血管破坏剂临床评估中的动态对比增强磁共振成像生物标志物
Br J Cancer. 2007 Jan 29;96(2):189-95. doi: 10.1038/sj.bjc.6603515. Epub 2007 Jan 9.
9
Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy.动态对比增强磁共振成像作为肿瘤放疗反应的预测指标。
Lancet Oncol. 2007 Jan;8(1):63-74. doi: 10.1016/S1470-2045(06)71012-9.
10
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.动态对比增强磁共振成像作为一种成像生物标志物。
J Clin Oncol. 2006 Jul 10;24(20):3293-8. doi: 10.1200/JCO.2006.06.8080.